OurBoard

Katherine E. Warren, MD

Dr. Warren leads preclinical and clinical efforts in developing new therapeutic strategies for the treatment of children with tumors of the central nervous system. She has extensive experience in drug development for children with CNS tumors, including preclinical pharmacokinetic studies, and early phase clinical trials in children. Her research entails a multifaceted approach in efforts to develop clinical trials with biologic and pharmacologic rationale and includes:

1. experimental therapeutics and noninvasive analysis of individual patients, including multiparametric imaging,
2. utilization of preclinical models to study CNS pharmacology of agents and alternate delivery methods, and
3. study of tumor biology to identify potentially druggable targets.

Areas of Expertise

1. brain tumors
2. pediatric clinical trials
3. diffuse intrinsic pontine glioma (DIPG)
4. drug delivery
5. multiparametric imaging
6. pharmacokinetics